BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 29295642)

  • 21. Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis.
    Bubik RJ; Barth DM; Hook C; Wolf RC; Muth JM; Mara K; Patnaik MS; Pruthi RK; Marshall AL; Litzow MR; Elliott MA; Hogan WJ; Shah MV; Begna KH; Alkhateeb H; Pardanani A; Ashrani AA; Call TG; Rivera CE; Camoriano JK; Go RS; Wolanskyj-Spinner AP; Parikh SA
    Leuk Lymphoma; 2020 Jul; 61(7):1592-1600. PubMed ID: 32157935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A high sIL-2R/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome.
    Tsuji T; Hirano T; Yamasaki H; Tsuji M; Tsuda H
    Ann Hematol; 2014 May; 93(5):821-6. PubMed ID: 24705932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignancy-associated hemophagocytic lymphohistiocytosis in Sweden: incidence, clinical characteristics, and survival.
    Löfstedt A; Jädersten M; Meeths M; Henter JI
    Blood; 2024 Jan; 143(3):233-242. PubMed ID: 37595287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution.
    Gupta AA; Tyrrell P; Valani R; Benseler S; Abdelhaleem M; Weitzman S
    J Pediatr Hematol Oncol; 2009 Feb; 31(2):81-4. PubMed ID: 19194188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial and acquired hemophagocytic lymphohistiocytosis.
    Janka G; zur Stadt U
    Hematology Am Soc Hematol Educ Program; 2005; ():82-8. PubMed ID: 16304363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes.
    Tamamyan GN; Kantarjian HM; Ning J; Jain P; Sasaki K; McClain KL; Allen CE; Pierce SA; Cortes JE; Ravandi F; Konopleva MY; Garcia-Manero G; Benton CB; Chihara D; Rytting ME; Wang S; Abdelall W; Konoplev SN; Daver NG
    Cancer; 2016 Sep; 122(18):2857-66. PubMed ID: 27244347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary Hemophagocytic Lymphohistiocytosis: Do We Really Need Chemotherapeutics for All Patients?
    Haytoglu Z; Yazici N; Erbay A
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):e106-e109. PubMed ID: 28060133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperferritinemia in Critically Ill Patients.
    Lachmann G; Knaak C; Vorderwülbecke G; La Rosée P; Balzer F; Schenk T; Schuster FS; Nyvlt P; Janka G; Brunkhorst FM; Keh D; Spies C
    Crit Care Med; 2020 Apr; 48(4):459-465. PubMed ID: 32205591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated Interleukin-10 Levels Are Associated with Low Platelet Count and Poor Prognosis in 90 Adult Patients with Hemophagocytic Lymphohistiocytosis.
    Hao L; Ren J; Zhu Y; Ma Y; Pan J; Yang L
    Int Arch Allergy Immunol; 2023; 184(4):400-408. PubMed ID: 36634629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore.
    Knaak C; Nyvlt P; Schuster FS; Spies C; Heeren P; Schenk T; Balzer F; La Rosée P; Janka G; Brunkhorst FM; Keh D; Lachmann G
    Crit Care; 2020 May; 24(1):244. PubMed ID: 32448380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review.
    Lin M; Park S; Hayden A; Giustini D; Trinkaus M; Pudek M; Mattman A; Schneider M; Chen LYC
    Ann Hematol; 2017 Aug; 96(8):1241-1251. PubMed ID: 28497365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
    J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver transplantation for children with acute liver failure associated with secondary hemophagocytic lymphohistiocytosis.
    Amir AZ; Ling SC; Naqvi A; Weitzman S; Fecteau A; Grant D; Ghanekar A; Cattral M; Nalli N; Cutz E; Kamath B; Jones N; De Angelis M; Ng V; Avitzur Y
    Liver Transpl; 2016 Sep; 22(9):1245-53. PubMed ID: 27216884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of soluble CD163 and soluble CD25 in diagnosis and treatment of children with hemophagocytic lymphohistiocytosis].
    Wang Y; Liu D; Zhu G; Yin C; Sheng G; Zhao X
    Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):824-9. PubMed ID: 26758320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnostic significance of glycosylated ferritin for patients with secondary hemophagocytic lymphohistiocytosis].
    Wang YN; Wang Z; Wang JS; Feng CC; Tian LP; Wu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1379-82. PubMed ID: 19099648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
    Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J
    Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphoid malignancy-associated hemophagocytic lymphohistiocytosis: Search for the hidden source.
    Bains A; Mamone L; Aneja A; Bromberg M
    Ann Diagn Pathol; 2017 Jun; 28():37-42. PubMed ID: 28648938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of mycobacterial infection associated hemophagocytic lymphohistiocytosis with etoposide and anti-tuberculous therapy: a case report.
    Wang YH; Ba JH; Shi XW; Wu BQ
    BMC Infect Dis; 2020 May; 20(1):321. PubMed ID: 32370734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a retrospective study of increasing awareness of a disease from a single-center in China.
    Li F; Yang Y; Jin F; Dehoedt C; Rao J; Zhou Y; Li P; Yang G; Wang M; Zhang R; Yang Y
    Orphanet J Rare Dis; 2015 Feb; 10():20. PubMed ID: 25757854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of bone marrow hemophagocytosis in adult patients with malignancy and non-malignancy-induced hemophagocytic lymphohistiocytosis.
    Lim SH; Park S; Jang JH; Kim K; Kim HJ; Kim SH; Kang CI; Chung DR; Peck KR; Lee J; Cha HS; Koh EM; Ko YH; Kim WS; Jung CW; Kim SJ
    Ann Hematol; 2016 Jan; 95(2):325-35. PubMed ID: 26453074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.